Table 2.

Categories Determined by Chart Review for Samples and Patients Included in the Analysis

CategorySamplesUnique Patients
Never SARS-CoV-2 positive14161249
 Same-day negative test194194
Ever SARS-CoV-2 positivea444360
 Convalescent182153
 Late presenting3030
 Acute141130
 Sampled 3 or more days prior to diagnosis4234
 Negative interim testing2116
CategorySamplesUnique Patients
Never SARS-CoV-2 positive14161249
 Same-day negative test194194
Ever SARS-CoV-2 positivea444360
 Convalescent182153
 Late presenting3030
 Acute141130
 Sampled 3 or more days prior to diagnosis4234
 Negative interim testing2116
a

Includes in-hospital nucleic acid amplification tests (NAAT) as well as community NAAT or antigen testing if reported in the clinical narrative.

Table 2.

Categories Determined by Chart Review for Samples and Patients Included in the Analysis

CategorySamplesUnique Patients
Never SARS-CoV-2 positive14161249
 Same-day negative test194194
Ever SARS-CoV-2 positivea444360
 Convalescent182153
 Late presenting3030
 Acute141130
 Sampled 3 or more days prior to diagnosis4234
 Negative interim testing2116
CategorySamplesUnique Patients
Never SARS-CoV-2 positive14161249
 Same-day negative test194194
Ever SARS-CoV-2 positivea444360
 Convalescent182153
 Late presenting3030
 Acute141130
 Sampled 3 or more days prior to diagnosis4234
 Negative interim testing2116
a

Includes in-hospital nucleic acid amplification tests (NAAT) as well as community NAAT or antigen testing if reported in the clinical narrative.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close